Long-term survival in patients with localized pancreatic adenocarcinoma (PDAC) or ampullary adenocarcinoma (AA) who undergo resection is rare, even in lymph node (LN)-negative disease…
Long-term survival in patients with localized pancreatic adenocarcinoma (PDAC) or ampullary adenocarcinoma (AA) who undergo resection is rare, even in lymph node (LN)-negative disease…
Long-term survival in patients with localized pancreatic adenocarcinoma (PDAC) or ampullary adenocarcinoma (AA) who undergo resection is rare, even in lymph node (LN)-negative disease…
Background: Sarcomas are rare mesenchymal tumors with a propensity for hematogenous metastasis, leading to liver metastasis. Advancements in liver surgery have led to increased resection of sarcomatous liver metastasis as discussed in several studies…
Pancreatic ductal adenocarcinoma (PDAC) exists in several morphological subtypes differing in prognostic significance. However, to date, a clinico-morphological correlation of these subtypes in the context of neoadjuvant therapy (NAT) has not been performed…
To achieve adequate surgical exposure of the third portion of the duodenum, the Cattell-Braasch maneuver or right colon mobilization is generally required…
IMPORTANCE: Guidelines recommend surgical exploration in selected patients with locally advanced pancreatic cancer (LAPC) following induction chemotherapy…
Sentinel node navigated surgery (SNNS) might offer a less invasive alternative to esophagectomy to tailor the extent of lymphadenectomy in patients with high-risk T1 esophageal adenocarcinoma (EAC)…
Pancreatic Adenocarcinoma (PDAC) is highly lethal due to overwhelming metastatic burden. The mechanisms underpinning metastasis in PDAC are lacking. The TMEM doorway is the sole portal of intravasation in breast cancer (BC)…
Pancreatic Adenocarcinoma (PDAC) is highly lethal due to overwhelming metastatic burden. The mechanisms underpinning metastasis in PDAC are lacking. The TMEM doorway is the sole portal of intravasation in breast cancer (BC)…
INTRODUCTION: Carcinoembryonic antigen (CEA) levels may change after preoperative chemotherapy discontinuation before surgery for colorectal liver metastases (CLM)…
Early loss of mesoportal venous patency after reconstruction during pancreatectomy is often due to technical factors, whereas delayed loss is often associated with disease recurrence…
Formerly validated risk-stratified pancreatectomy clinical pathways decreased index hospitalization stay without increasing readmissions, which remain major contributors to the financial burden of pancreatectomy…
Prognosis after hepatectomy for multifocal intrahepatic cholangiocarcinoma (iCCA) is worse than for unifocal iCCA with reported post-operative survival of under 2 years. As a result, multifocality must be carefully considered prior to resection…
INTRODUCTION: Variations in hepatic arterial and portal venous anatomy have previously been described; however, a comprehensive evaluation of hepatic vascular anatomy that includes other critical elements relevant to hepatectomy is lacking…
INTRODUCTION: Pathologic response after preoperative chemotherapy has been associated with overall survival, and RAS mutational status could stratify patients with minor pathologic response (>50%)…
Background: Surgeons may consider parenchymal-sparing (PSH) or one-stage major hepatectomy (MH) for patients with bilateral colorectal liver metastases (CLM). However, outcomes of these two approaches for patients with advanced bilateral disease are underreported…